Apriori Bio
MA - CambridgeBiotechnology
Focus: Apriori Bio is an AI-focused biotechnology platform company specializing in viral variant identification, founded in 2020 and based in Cambridge, MA. The company is actively recruiting across 79 open positions, indicating growth-stage expansion.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
82+24 this month
Hot — 67 jobs added in 30d
Net +24 (67 new, 43 removed). Aggressive expansion phase.
Should You Work at Apriori Bio?
AI assessmentApriori Bio is a high-risk, high-potential-impact opportunity suited for technologists and scientists seeking to build from the ground up in AI-driven drug discovery, but with minimal visibility into path to sustainability.
Why Work Here
- Heavy R&D hiring (26 roles) and Data Science focus (12 roles) indicate core investment in platform development and AI-driven innovation
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Apriori Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.